Order results by:
| Issue | Title | |
| Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
| "... are shown. Use of NOAC in reduced doses prescribing according to RCT and RWD are shown. Our own 13-month ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova | ||
| "... oral anticoagulants (NOAC): 1) none of the randomized controlled trials (RCTs) with NOAC (except ..." | ||
| Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
| Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
| "... controlled trials (RCTs) with NOAC (except for two RCTs with rivaroxaban – EINSTEIN-DVT and EINSTEIN-PE ..." | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... and meta-analyses (PRISMA)”. Results. The meta-analysis included 5 RCTs. NOACs were as effective ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... and meta-analyses (PRISMA)”. Results. The meta-analysis included 5 RCTs. NOACs were as effective ..." | ||
| Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
| S. Yu. Martsevich, Y. V. Lukina | ||
| "... . All NOAC were studied in randomized clinical trials (RCTs) in comparison with warfarin, mainly ..." | ||
| Vol 6, No 4 (2010) | RUSSIAN CLINICAL TRAILS IN CARDIOLOGY. YESTERDAY, TODAY AND TOMORROW | Abstract similar documents |
| S. A. Shalnova, S. Y. Martsevich | ||
| "... The organization of randomized clinical trials (RCTs) in accordance to the principles of Good ..." | ||
| Vol 12, No 5 (2016) | Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko | ||
| "... The role of randomized controlled trials (RCTs) and observational studies in evaluation ..." | ||
| Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
| N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
| "... patients with AF and VTE, since its efficacy and safety have been established in RCTs and specially ..." | ||
| Vol 14, No 5 (2018) | News of the Annual Congress of the European Society of Cardiology in Munich: Research to Help Practical Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... clinical trials (RCTs) are reviewed. The RCTs presented at the congress were mainly devoted not to new ..." | ||
| Vol 15, No 4 (2019) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part I. Motives for the Patients' Participation in Clinical Trials | Abstract similar documents |
| S. Yu. Martsevich, N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva | ||
| "... (RCT), and their adherence to monitoring in medical institutions were determined. This publication ..." | ||
| Vol 13, No 2 (2017) | ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES | Abstract similar documents |
| S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... The role of randomized controlled trials (RCTs) and observational studies in evaluation ..." | ||
| Vol 15, No 3 (2019) | Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it? | Abstract similar documents |
| N. O. Vasyukova, Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. I. Zvonareva | ||
| "... adherence. Randomized clinical trials (RCT) are the basis of evidence-based medicine, the results obtained ..." | ||
| Vol 13, No 1 (2017) | DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT | Abstract similar documents |
| D. А. Napalkov, A. A. Sokolova, V. V. Fomin | ||
| "... The review actualizes the need to validate data obtained in randomized clinical trials (RCT ..." | ||
| Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
| L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 15, No 5 (2019) | Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies | Abstract similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... controlled trial (RCT) of IONA (the Impact Of Nicorandil in Angina). To study whether the results of RCTs ..." | ||
| Vol 19, No 4 (2023) | Systematic review and meta-analysis: a critical examination of the methodology | Abstract similar documents |
| S. Yu. Martsevich S.Yu., A. R. Navasardyan, K. V. Lobastov, M. V. Mikaelyan, E. V. Mikhaylenko, A. Yu. Suvorov, I. V. Schastlivtsev, O. N. Dzhioeva, V. V. Matveev, E. S. Akimova, V. V. Sytkov, E. Dubar, O. M. Drapkina | ||
| "... professionals. According to this concept, data from randomized clinical trials (RCTs) are considered lower ..." | ||
| Vol 17, No 4 (2021) | Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology | Abstract similar documents |
| O. N. Tkacheva, Yu. V. Kotovskaya, N. K. Runikhina, E. V. Frolova, V. S. Ostapenko, N. V. Sharashkina, E. I. Baranova, S. V. Bulgakova, S. V. Villevalde, D. V. Duplyakov, A. N. Ilnitskiy, O. A. Kislyak, Zh. D. Kobalava, A. O. Konradi, S. V. Nedogoda, Ya. A. Orlova, N. V. Pogosova, K. I. Proshchaev, G. A. Chumakova | ||
| "... as cognitive decline and loss of autonomy in the elderly and old age. Randomized clinical trials (RCTs ..." | ||
| Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
| V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
| "... (2,0-3,0) was in 111/281 (39,5%) patients. 57,7% (384/665) outpatients with AF received NOAC ..." | ||
| Vol 16, No 6 (2020) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy | Abstract similar documents |
| N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva, S. Yu. Martsevich | ||
| "... (RCT) in the period from 2011 to 2018. A control group (n=109) included patients who had never ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... , which presents the design and main characteristics of randomized clinical trials (RCTs) and systematic ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
| Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
| S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
| "... favorable profile of drug interaction in comparison with other new oral anticoagulants (NOAC). The basis ..." | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention ..." | ||
| Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
| Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
| "... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
| Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
| S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
| "... тактики применения прямых пероральных антикоагулянтов (ПОАК). Приводятся клинические ситуации, при которых ..." | ||
| Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
| S. R. Gilyarevskiy | ||
| "... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
| Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... , влияющего на эффективность и безопасность применения прямых пероральных антикоагулянтов (ПОАК) в клинической ..." | ||
| Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
| A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
| "... problems. New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however ..." | ||
| Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
| A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
| "... – ингибиторах действия прямых оральных антикоагулянтов (ПОАК), которые могут быть использованы в качестве ..." | ||
| Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
| O. V. Gaisenok, A. S. Leonov | ||
| "... OAC (NOAC), prescription depending type AF and the reasons for their not-prescribing were studied ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... . In connection with the known disadvantages of warfarin use, the elaboration of new oral anticoagulants (NOAC ..." | ||
| Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
| "... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..." | ||
| Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
| A. V. Rudakova | ||
| "... oral anticoagulants (NOACs). Material and methods. Cost-effectiveness analysis was performed using ..." | ||
| Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
| A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
| "... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
| Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
| A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
| "... in a nonrandomized observational study of new oral anticoagulants (NOAC) in real clinical practice. A history ..." | ||
| Vol 18, No 5 (2022) | Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
| Z. A. Gebekova, I. I. Ivanov, A. Asambayeva, A. I. Skripka, A. A. Sokolova, D. A. Napalkov, T. A. Vuimo | ||
| "... ), принимающих различные прямые оральные антикоагулянты (ПОАК), с помощью теста «Тромбодинамика». Материалы и ..." | ||
| Vol 18, No 4 (2022) | Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants | Abstract similar documents |
| D. V. Pevzner, N. S. Kostritca, A. K. Alieva, I. A. Merkulova, I. S. Yavelov, E. V. Merkulov, I. E. Chazova | ||
| "... ушка левого предсердия (УЛП), применении прямых оральных антикоагулянтов (ПОАК) или варфарина ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... (ПОАК), возможность использования которых при тромбозе ЛЖ активно изучается. На текущий момент ..." | ||
| Vol 14, No 2 (2018) | WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY | Abstract similar documents |
| R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin | ||
| "... warfarin, 15% new oral anticoagulants (NOAC). The majority of patients received antiplatelet agents ..." | ||
| Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
| Yu. P. Skirdenko, N. A. Nikolaev | ||
| "... антикоагулянты (ПОАК) (χ2=1,44; p<0,49, Pearson), и значимо большим у лиц, принимающих варфарин (как в сравнении ..." | ||
| Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
| N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
| "... (ПОАК). Выбор конкретного препарата должен основываться на результатах рандомизированных клинических ..." | ||
| Vol 6, No 4 (2010) | THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (PART II) | Abstract similar documents |
| Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. Getzsche, Thomas Lang, N. Chipigina | ||
| "... , свидетельствующие о недостаточном качестве отчетов о результатах рандомизированных контролируемых испытаний (РКИ ..." | ||
| Vol 6, No 5 (2010) | THE REVISED CONSORT STATEMENT FOR REPORTING RANDOMIZED TRIALS: EXPLANATION AND ELABORATION (2001) (CONTINUATION) | Abstract similar documents |
| Douglas G. Altman, Kenneth F. Schulz, David Moher, Matthias Egger, Frank Davidoff, Diana Elbourne, Peter C. G tzsche, Thomas Lang, N. Chipigina | ||
| "... качестве отчетов о результатах рандомизированных контролируемых испытаний (РКИ). Недавно проведенные ..." | ||
| Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
| К. V. Lobastov, I. V. Schastlivtsev | ||
| "... оральных антикоагулянтов (ПОАК) изменило ситуацию. В сравнении с АВК они обладают более высокой ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... , получающих постоянную терапию прямыми пероральными антикоагулянтами (ПОАК). Материал и методы. В анализ ..." | ||
| Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
| A. I. Kochetkov, O. D. Ostroumova | ||
| "... антикоагулянтов (ПОАК) по сравнению с антагонистами витамина К в связи с обширной доказательной базой ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... oral anticoagulants (NOACs), 213 (49.6%) – warfarin, 156 (36.4%) – did not take any oral anticoagulant ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... применение как антагонистов витамина К (варфарина), так и прямых оральных антикоагулянтов (ПОАК): дабигатрана ..." | ||
| Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
| E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
| "... неклапанной фибрилляцией предсердий, получающих варфарин и прямые оральные антикоагулянты (ПОАК). Материал и ..." | ||
| Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
| "... добавлением прямых оральных антикоагулянтов (ПОАК). Материал и методы. Выполнено открытое сравнительное ..." | ||
| Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
| "... прогрессирования КН у пациентов с ФП, причем, особый приоритет отдается прямым оральным антикоагулянтам (ПОАК). В ..." | ||
| Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
| Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
| "... .7%; Kolmogorov-Smirnov; p<0.05). Patients receiving new oral anticoagulants (NOAC) have better compliance ..." | ||
| Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
| N. A. Novikova, A. N. Volovchenko | ||
| "... lately new oral anticoagulants (NOAC) are becoming more common for the prevention of thromboembolic ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... антикоагулянтов (ПОАК) в клинических руководствах по лечению венозных тромбоэмболических осложнений (ВТЭО) и ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... oral anticoagulants" or "direct oral anticoagulants" or "novel oral anticoagulant" or "NOAC" or "DOAC ..." | ||
| Vol 8, No 2 (2012) | ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS | similar documents |
| Lei Zhang, Yizhou Lu, Hong Jiang, Liming Zhang, Aijun Sun, Yunzeng Zou, Junbo Ge | ||
| "... Reviews был проведен поиск рандомизированных контролируемых испытаний (РКИ), оценивающих лечение ТМЗ у ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... витамина К (АВК), прямых пероральных антикоагулянтов (ПОАК) на костный метаболизм, минеральную плотность ..." | ||
| Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
| A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
| "... Вопрос о безопасности прямых оральных антикоагулянтов (ПОАК), несмотря на их высокую эффективность ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... по сравнению с другими, более мощными ингибиторами P2Y12 и прямым оральным антикоагулянтом (ПОАК ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... , включая 20 (46,5%) назначений прямых оральных антикоагулянтов (ПОАК), 17 (39,5%) варфарина и 6 (14 ..." | ||
| Vol 16, No 6 (2020) | An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? | Abstract similar documents |
| T. V. Pavlova | ||
| "... рандомизированных клинических исследований (РКИ) и в условиях ежедневной клинической практики. Оральный ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... сравнению с 2011-2012 гг. преимущественно за счет прямых ОАК (ПОАК). Частота применения антиагрегантной ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... ,6%), прямые оральные антикоагулянты (ПОАК) — 203 (43,8%) и варфарин — в 10 случаях (2,2%). У пациентов ..." | ||
| Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... , and also presents extrapolation of the results of RCTs to the real clinical practice (data of registers ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..." | ||
| 1 - 69 of 69 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
